Aphria Inc. (NASDAQ: APHA) Q3 2021 earnings call dated Apr. 12, 2021
Corporate Participants:
Carl Merton — Chief Financial Officer
Irwin D. Simon — Chief Executive Officer
Analysts:
Owen Bennett — Jefferies — Analyst
W. Andrew Carter — Stifel Financial Group — Analyst
Tamy Chen — BMO Capital Markets — Analyst
Aaron Grey — Alliance Global Partners — Analyst
Pablo Zuanic — Cantor Fitzgerald — Analyst
John Zamparo — CIBC Capital Markets — Analyst
Matt Bottomley — Canaccord Genuity — Analyst
Michael Lavery — Piper Sandler — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
What to expect when J.M. Smucker (SJM) reports Q2 2025 earnings results
Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Friday. The stock has dropped 6% over the past three months. The branded foods company is slated to report
Earnings Summary: Highlights of BJ’s Wholesale Club’s Q3 2024 results
Department store chain BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) has reported financial results for the third quarter of 2024, reporting a 3% increase in net sales. Adjusted earnings, on a
Listen On
